DANIEL J LEVANGIE
CIK 1187406 · EVP & President, Drug Delivery · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.13M
Companies
7
Total Filings
58
Lifetime Open-Market Net
-$70.14M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 34,312 | $104.91 | $3.60M | -$6.01M | 21 | 2025-06-16 |
| Renalytix plc (RNLX) Delisted | Director | — | $0.21 | — | $0 | 1 | 2023-11-22 |
| PODD | EVP & President, Drug Delivery | 21,122 | $148.38 | $3.13M | -$618.6K | 10 | 2016-05-02 |
| LIPOSCIENCE INC (LPDX) Delisted | Director | 11,122 | — | — | $41.7K | 2 | 2013-12-06 |
| ev3 Inc. (EVVV) Delisted | Director | 4,148 | — | — | $539.2K | 7 | 2010-07-13 |
| HOLOGIC INC (HOLX) Delisted | Director | 12,668 | $76.01 | $962.9K | -$17.69M | 5 | 2008-01-16 |
| CYTYC CORP (CYTC) Delisted | President, Surgical Products | 10,660 | — | — | -$46.40M | 9 | 2007-10-15 |
Recent Filings · Page 2 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-24 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,558 | $0 | EDGAR |
| 2019-08-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | — | -$4.79M | EDGAR |
| 2019-07-26 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,784 | $0 | EDGAR |
| 2018-07-30 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +4,401 | $0 | EDGAR |
| 2017-07-31 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +7,119 | $0 | EDGAR |
| 2016-08-01 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +15,156 | $0 | EDGAR |
| 2016-05-02 | PODD | Tax (F) | −652 | -$21.7K | EDGAR |
| 2016-04-05 | PODD | Tax (F) | −740 | -$24.8K | EDGAR |
| 2016-03-11 | PODD | Mixed | +12,701 | -$1.4K | EDGAR |
| 2016-03-09 | PODD | Sell (S) | −7,663 | -$238.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.